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ing. AraAbstract The interaction between Thioguanine (6-TG) and human serum albumin (HSA) under
simulative physiological conditions was studied using ﬂuorescence spectroscopy in combination
with UV absorption and molecular modeling method. A strong ﬂuorescence quenching reaction
of 6-TG to HSA was observed and the quenching mechanism was suggested as static quenching
according to the Stern–Volmer equation. The binding constants (K) at different temperatures as
well as thermodynamic parameters, enthalpy change (DH) and entropy change (DS), were calcu-
lated according to relevant ﬂuorescent data and thermodynamic equation. It was indicated that
the hydrophobic interaction was a predominant intermolecular force in order to stabilize the
copolymer, which was in agreement with the results of molecular modeling study. In addition,
the binding distance between 6-TG and the tryptophan residue of HSA was studied according to
Fo¨ster’s non-radiative energy transfer theory and the effects of common ions on the binding con-
stant of 6-TG-HSA copolymer were also discussed at room temperature.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Thioguanine (6-TG, Fig. 1) is an efﬁcient type of nucleoside
drug with a wide range of biological activities, such as antitu-
mor, antiviral and anticancer activities, which have signiﬁ-
cantly curative effect for acute lymphoblastic leukemia and
other tumors. The interactions between drugs and proteins6 373 3326336.
(F. Cui).
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tion rate of drugs. Therefore, the interaction of 6-TG and hu-
man serum albumin (HSA) is extremely important in life
science, biochemistry and clinical medicine. It is reported that
in 69 cases of the 6-TG treatments of acute leukemia, 70% is
efﬁcient, and 6-TG can also support other anticancer drugs
for the treatments of gastric cancer, lymph sarcoma and villus
epithelial cancer. When 6-TG enters the circulatory system, it
plays the role in anti-leukemia by HPRT direct catalytic guan-
ine phosphorylated form sulfur-based compounds (TGNs),
and also generates aerosol catalytic methylation of products
such as 6-meTG, or me-TGMP to achieve anti-tumor effect
(Evans and Relling, 1994).
Protein is an important chemical substance in our life and
the main target of all medicines in an organism. Seruming Saud University.
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Figure 1 The structure of Thioguanine (6-TG, C5H5N5S,
molecular weight 167.19).
2 X. An et al.albumin, the most abundant protein in the circulatory system,
is one of the most extensively studied proteins because it can
interact with many endogenous and exogenous substances.
Binding of drugs to plasma proteins is an important pharma-
cological parameter, since it frequently affects the distribution
and elimination of a drug as well as the duration and intensity
of its physiological action. The effect is especially signiﬁcant
for highly protein bound drugs, as only a small alteration in
bound fraction can produce a profound change in the pharma-
codynamically active free drug concentration (Li et al., 2012;
Seedher and Bhatia, 2006). The studies on this aspect can pro-
vide information of the structural features that determine the
therapeutic effectivity of drugs, and have become an interest-
ing research ﬁeld in life science, chemistry, biochemistry and
clinical medicine.
Among various methods concerning the interactions of
drugs and proteins, ﬂuorescence techniques are great aids in
the study of interactions between drugs and plasma proteins
in general and serum albumin in particular because of its high
sensitivity, rapidity, and ease of implementation (Bian et al.,
2004). The ﬂuorescence measurements can give information
such as the binding mechanism, binding mode, binding con-
stants, binding sites, intermolecular distance, etc. (Sulkowska,
2002). In addition, UV absorption measurement is a very sim-
ple method and applicable to explore the structure (Hu et al.,
2004) and the copolymer formation (Bi et al., 2005; Kandagal
et al., 2006). The molecular interactions are often monitored
by these methods because they have advantages in sensitivity
and efﬁciency over conventional approaches such as afﬁnity
and size exclusion chromatography, equilibrium dialysis, ultra-
ﬁltration and ultracentrifugation (Kandagal et al., 2006). The
modeling method is also used to enucleate the binding mode
between HSA and 6-TG.
This study was designed to investigate the copolymer
between 6-TG and HSA by spectroscopic in combination
with modeling method under simulative physiological condi-
tions. Attempts were made to investigate the binding mech-
anism between 6-TG and HSA regarding the binding
constants, the thermodynamic functions and the effect of
ions on the binding constants. Furthermore, the binding
mode was evaluated using the molecular modeling
method; the results were in good agreement with the ther-
modynamic parameters.
2. Experimental
2.1. Reagents
Appropriate amount of human serum albumin (Sigma) was
directly dissolved in water to the prepare stock solution atPlease cite this article in press as: An, X. et al., The investigation o
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the dark at 0–4 C; 2.0 · 104 mol L1 6-TG (synthesized
by the microwave-assisted methods without solvent) solution
was obtained by dissolving it in double distilled water;
0.5 mol L1 NaCl working solution, 0.1 mol L1 Tris–HCl
buffer solution of pH 7.4 and 1.0 mg mL1 other ionic solu-
tions were prepared. Unless otherwise mentioned, all chemi-
cals were of analytical reagent grade and used without
further puriﬁcation. Double distilled water was used through-
out the experiments.
2.2. Apparatus
All ﬂuorescence measurements were carried out on a FP-6200
spectroﬂuorimeter (JASCO, Japan) and RF-540 spectroﬂuo-
rimeter (Shimadzu, Japan) equipped with a thermostat bath
and 1.0 cm quartz cells, using 5/5 nm slit widths. The pH val-
ues were measured on a pH-3 digital pH-meter (Shanghai Lei
Ci Device Works, Shanghai, China) with a combined glass
electrode. All calculations were performed on SGI workstation
while studying the molecular model.
2.3. Optimization of experimental conditions
In order to get the best results, the optimal conditions were
investigated. Various experimental parameters including med-
ium, pH, and addition order and reaction temperature were
studied with 6-TG concentration being 0.4 · 106 mol L1 in
all conditions. As a result, 0.1 mol L1 Tris–HCl buffer solu-
tion of pH 7.4 was chosen as the supporting media; the se-
quence of Tris–HCl + NaCl + HSA+ 6-TG was selected
and 24 C was suggested as the preferable reaction
temperature.
2.4. Measurements of spectra
According to the optimum physiological conditions, 2.0 mL
Tris–HCl buffer solution, 2.0 mL NaCl solution, appropriate
amounts of HSA and 6-TG were added to a 10.0 mL standard
ﬂask and diluted to 10.0 mL with double distilled water. Fluo-
rescence quenching spectra of HSA were obtained at excitation
wavelength (280 nm) and emission wavelength (300–450 nm).
Fluorescence spectra in the presence of other ions and synchro-
nous ﬂuorescence spectra were also measured at the same con-
ditions. In addition, the UV absorption spectra of different
systems were recorded.
3. Results and discussion
3.1. The ﬂuorescence quenching studies
HSA has three intrinsic ﬂuorophores, viz tryptophan, tyrosine,
and phenylalanine residues (Tang et al., 2006). Actually, the
intrinsic ﬂuorescence of HSA is almost contributed by trypto-
phan alone and this viewpoint was supported by the experi-
mental observation of Sulkowska (2002). The change of
intrinsic ﬂuorescence intensity of HSA is from the tryptophan
residue when small molecule substances are bound to HSA.
Fig. 2 shows the ﬂuorescence emission spectra of HSA at var-
ious concentrations of 6-TG. HSA had a strong ﬂuorescencef interaction between Thioguanine and human serum albumin
4), http://dx.doi.org/10.1016/j.arabjc.2013.06.031
Figure 2 The ﬂuorescence quenching spectra of HSA with
different concentrations of 6-TG with the excited wavelength at
280 nm in Tris–HCl butter solution (pH= 7.4) at 24 C,
CHSA = 2.0 · 106 mol L1. From 1 to 6 the C6-TG was 0, 0.4,
0.8, 1.2, 1.6, 2.0 · 106 mol L1, respectively.
Table 1 The quenching constants (L mol1 s1) of the 6-TG-
HSA system at different temperatures.
T(C) Stern–Volmer equation Kq (L mol1 s1) R
24 Y= 0.9987 + 3.106 · 104[Q] 3.106 · 1012 0.9995
34 Y= 1.0014 + 2.853 · 104[Q] 2.853 · 1012 0.9993
44 Y= 1.0017 + 2.698 · 104[Q] 2.698 · 1012 0.9973
The investigation of interaction between Thioguanine and human serum albumin by ﬂuorescence and modeling 3emission band at 344 nm, and the ﬂuorescence emission inten-
sity of HSA decreased regularly with increasing the concentra-
tion of 6-TG. At the same time, blue shift of the maximum
emission wavelength occurred. These phenomena indicated
that the interaction took place between 6-TG and HSA, and
the microenvironment around the Trp-214 residue was chan-
ged after the addition of 6-TG (Trynda-Lemiesz et al., 1999).
The quenching rate constants decreased with increasing
temperature for the static quenching, while reversed effect
was observed for the dynamic quenching (Chen et al., 1990).
The possible quenching mechanism could be interpreted by
the ﬂuorescence quenching spectra of the proteins and the
F0/F[Q] (Stern–Volmer) curves of HSA with 6-TG at differ-
ent temperatures (24, 34 and 44 C).
As shown in Fig. 3, the Stern–Volmer plots were linear and
the slopes decreased with increasing temperature, which was
consistent with the static type of quenching mechanism. The
Ksv and correlation coefﬁcient values, r (the linear relationship0 2 4 6 8 10
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Figure 3 The Stern–Volmer curves of HSA with 6-TG at pH 7.4;
CHSA and C6-TG are the same as those in Fig. 2.
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listed in Table 1. The result showed that the possible quench-
ing mechanism between 6-TG and HSA was static quenching
instead of dynamic quenching. In order to conﬁrm this point,
the procedure was assumed to be dynamic quenching. The
ﬂuorescence quenching data were analyzed by the Stern–Vol-
mer equation:
F0=F ¼ 1þ Kqs0½Q ¼ 1þ Ksv½Q ð1Þ
Where F0 and F are the ﬂuorescence intensities in the absence
and presence of quenchers, respectively. Kq, Ksv, s0 and [Q] are
the quenching rate constant of the biomolecule, the Stern–Vol-
mer quenching constant, the average lifetime of molecule with-
out quencher and concentration of quencher, respectively.
Obviously:
Ksv ¼ Kqs0 ð2Þ
Taking average lifetime of biomolecule ﬂuorescence as around
108 s (Lakowicz and Weber, 1973), an approximate quench-
ing constant (Kq, L mol
1 s1) could be obtained according
to the Eq. (2). The results are also listed in Table 1.
The maximum scatter collision quenching constant of var-
ious quenchers with the biopolymer is 2.0 · 1010 L mol1 s1
(Ware, 1962). Obviously, the rate constant of protein quench-
ing procedure initiated by 6-TG was greater than the Kq of the
scatter procedure. This conﬁrmed that the quenching was not
initiated by dynamic collision but from the formation of a new
copolymer.
The UV absorption spectra were also utilized to enucleate
interaction of 6-TG with HSA. Fig. 4 shows the UV absorp-
tion spectra of HSA in the absence and presence of differentFigure 4 UV absorption spectra of HSA in tris–HCl buffer
solution (pH 7.4, 24 C) in the presence of different 6-TG
concentrations from 1 to 3: (1) 0.8 · 106 mol L1, (2)
0.4 · 106 mol L1, (3) CHSA = 2.0 · 106 mol L1, (4) the spec-
tra of 6-TG, C6-TG = 0.4 · 106 mol L1.
f interaction between Thioguanine and human serum albumin
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Figure 5 The Scatchard curves of quenching of HSA with 6-TG.
4 X. An et al.concentrations of 6-TG under the simulative physiological
conditions. HSA had a strong absorbance with a peak at
212 nm and the absorbance increased with the addition of 6-
TG. Meanwhile, the formation of the chromophore of 6-TG-
HSA resulted in the distinct shift of 6-TG-HSA spectrum to-
ward longer wavelength, indicating that a new copolymer
was formed between HSA and 6-TG.
3.2. The binding constants and binding sites
In drug-protein binding studies, ﬂuorescence quenching dates
were used to calculate binding constant and the number of
binding sites by Scatchard (1949):
r=Df ¼ nK rK ð3Þ
Where r represents the number of moles of bound drug per
mole of protein, Df represents the concentration of unbound
drug, K is the binding constant, and n is the number of binding
sites. The slope of r/Df  r plot gives the binding constant and
the number of binding sites that can be obtained from the
intercept.
Fig. 5 shows the Scatchard plots for the 6-TG-HSA system
at different temperatures. The linearity of the Scatchard plot
indicated that 6-TG binds to a single class of binding sites
on HSA, which was in agreement with the number of binding
site n; and the binding constants (K) decreased with increasing
the temperature. The binding constants and the number of
binding sites are summarized in Table 2. It could be concluded
that there was a strong interaction of HSA with 6-TG which
was weakened when the temperature increased, while the effect
of temperature was small.
3.3. The binding modes
The forces acting between drugs and biomolecules are com-
posed of weak interactions of molecules such as hydrogenTable 2 The binding parameters and thermodynamic parameters o
T(C) K (L mol1) n DG (k
24 4.24 · 104 0.8073 26.3
34 3.13 · 104 0.9799 26.4
44 2.47 · 104 1.1192 26.6
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and the hydrophobic interaction (Leckband, 2000). The ther-
modynamic parameters, enthalpy change (DH) and entropy
change (DS) of binding reaction are the main evidence for con-
ﬁrming binding modes. From the thermodynamic standpoint,
DH> 0 and DS> 0 implies a hydrophobic interaction;
DH< 0 and DS< 0 reﬂects the van der Waals force or hydro-
gen bond formation; and DH  0 and DS> 0 suggests an elec-
trostatic force (Ross and Subramanian, 1981).
The temperature dependence of the binding constants was
studied at different temperatures (24, 34 and 44 C). Because
the temperature effect was very small, the interaction enthalpy
change could be regarded as a constant if temperature range
was not too wide. Thus, DH and DS were considered to be con-
stants. According to the following thermodynamic equations:
lnK ¼ DH=RTþ DS=R ð4Þ
DG ¼ DH TDS ¼ RTlnK ð5Þ
Where K is the binding constant at corresponding temperature
and R is the gas constant, DH and DS of reaction could be
determined from the linear relationship between lnK and the
reciprocal absolute temperature. The free energy change
(DG) could be calculated by the Eq. (5). The results are repre-
sented in Table 2.
As shown in Table 2, DG and DH were negative, while DS
was positive. Therefore, the formation of 6-TG-HSA coordi-
nation compound was spontaneous and exothermic reaction
accompanied a positive DS value. According to the views of
Orwcora and Bochs (1996), Masaki Otagiri (Mohammed
et al., 1993), and Ross and Subramanian (1981), the positive
DS value is frequently taken as an evidence for hydrophobic
interaction. Furthermore, speciﬁc electrostatic interactions be-
tween ionic species in aqueous solution are characterized by a
positive value of DS and a negative DH value. Accordingly, it
was not possible to account for the thermodynamic parameters
of 6-TG-HSA compound on the basis of a single interaction
molecular force model (Gonzalez et al., 1992). It was more
likely that hydrophobic and electrostatic interactions were in-
volved in the binding process. However, 6-TG might be con-
sidered to be largely unionized under the experimental
conditions, as could be expected from its structure. Thus, elec-
trostatic interaction could not play a major role in the binding,
and 6-TG bound to HSA was mainly based on the hydropho-
bic interaction.
3.4. The energy transfer of 6-TG with HSA
According to Fo¨rster (1996) non-radiative energy transfer the-
ory, the rate of energy transfer depends on: (i) the relative ori-
entation of the donor and acceptor dipoles, (ii) the extent of
overlap of the emission spectrum of the donor with the absorp-
tion spectrum of the acceptor and (iii) the distance between the
donor and the acceptor. The energy transfer effect is relatedf 6-TG-HSA.
J mol1) DH (kJ mol1) DS (J mol1 K1)
1 -21.11 17.5
2
6
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The investigation of interaction between Thioguanine and human serum albumin by ﬂuorescence and modeling 5not only to the distance between the acceptor and the donor,
but also to the critical energy transfer distance R0, that is
E ¼ R60=ðR60 þ r6Þ ð6Þ
Where r is the distance between the acceptor and the donor
and R0 is the critical distance when the transfer efﬁciency is
50%, which can be calculated by
R60 ¼ 8:8 1025k2N4/J ð7Þ
Where k2 is the spatial orientation factor between the emission
dipole of the donor and the absorption dipole of the acceptor.
The dipole orientation factor, k2 is the least certain parameter
in the calculation of the critical transfer distance, R0. Although
theoretically k2 can range from 0 to 4, the extreme values re-
quire very rigid orientations. If both the donor and acceptor
are tumbling rapidly and free to assume any orientation, then
k2 equals 2/3 (Yang, 1991). If only the donor is free to rotate,
then k2 can vary from 1/3 to 4/3 (Wu and Stryer, 1972; Lako-
wicz, 1983), N is the refractive index of the medium, / the ﬂuo-
rescence quantum yield of the donor and J is the overlap
integral of the ﬂuorescence emission spectrum of the donor
and the absorption spectrum of the acceptor, given by
J ¼ RFðkÞðkÞk4Dk=RFðkÞDk ð8Þ
where F (k) is the ﬂuorescence intensity of the ﬂuorescent do-
nor in wavelength k and dimensionless, e (k) is the molar
absorption coefﬁcient of the acceptor in wavelength k and unit
is cm1 mol1 L. The energy transfer efﬁciency is frequency
calculated from the relative ﬂuorescence yield in the presence
(F) and absence of acceptor (F0):
E ¼ 1 F=F0 ð9Þ
The overlap of UV absorption spectra of 6-TG with the ﬂuo-
rescence emission spectra of HSA is shown in Fig. 6. J can be
evaluated by integrating the spectra in Fig. 6.
It was reported for HSA that k2 = 2/3, /= 0.118 and
N= 1.336 (Yu et al., 2013), so the value of the overlap integral
calculated from Fig. 6 is 4.1235 · 1014 cm3 L mol1, and R0 is
3.10 nm and r is 4.37 nm, respectively. The binding distance
between 6-TG and tryptophan residue of HSA is 4.37 nm,
which is smaller than 7 nm. According to conditions of Fo¨s-Figure 6 The overlap of UV absorption spectrum of 6-TG with
the ﬂuorescence emission spectrum of HSA. (a) The ﬂuorescence
emission spectrum of HSA (2.0 · 106 mol L1); (b) The UV
absorption spectrum of 6-TG (0.4 · 106 mol L1).
Please cite this article in press as: An, X. et al., The investigation o
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ing interaction between HSA and 6-TG could be conﬁrmed.
3.5. The effect of coexisting foreign substances on binding
constant
The previous studies indicated that HSA has a high-afﬁnity
metal-binding site at N-terminus. The multiple binding sites
underlie the exceptional ability of HSA to interact with many
organic and inorganic molecules and make this protein an
important regulator of intercellular ﬂuxes and the pharmacoki-
netic behavior of many drugs (Carter and Ho, 1994). There-
fore, the existence of other ions can directly inﬂuence the
binding force of small molecules with protein. The effect of
other ions on binding constants was investigated by analyzing
their different binding constants, which can be used as a model
for investigating the interaction of 6-TG with HSA. Table 3
summarizes the results of the effect of common ions on binding
constants at 24 C.
It was shown that the binding constants between the pro-
tein and 6-TG increased in the presence of other ions, signify-
ing a stronger binding between 6-TG and HSA. The higher
binding constant obtained in the presence of ions might result
from the interaction of cation/anion with 6-TG to form a com-
plex, which in turn interacted with HSA. From the pharmaco-
kinetics perspective, the increasing of the binding constant
would abate the drug concentration in the blood and prolong
the duration in the plasma in some way. Hence, maximum
effectiveness of the drug was achieved. Thus, the increase in
the binding constant of 6-TG-HSA in the presence of ions de-
scribed above prolonged the storage time in blood plasma and
enhanced the maximum effectiveness of 6-TG. Therefore, in
the presence of other ions, 6-TG could be stored and trans-
ferred better and released slower action by the protein in the
body (He et al., 2005).
3.6. Molecular model study
The complementary applications of molecular modeling have
been employed by computer methods to help the understand-
ing of the interaction of 6-TG with HSA. The investigation of
3-D structure of crystalline albumin showed that HSA con-
tains three homologous domains (I, II and III): I (residues
1–195), II (196–383), and III (384–585) and each domain can
be divided into two subdomains (A and B). The crystallo-
graphic analysis reveals that HSA has binding sites of com-Table 3 The binding constants (L mol1) of 6-TG-HSA at
24 C in the presence of common ions.
Ions KHSA(10
4) RHSA Ions KHSA (10
4) RHSA
K+ 4.0643 0.9999 Mg2+ 6.1108 0.9998
Ca2+ 5.7784 0.9997 Pb2+ 6.5945 0.9999
NH4
+ 5.4533 0.9998 Al3+ 6.9182 0.9995
Bi3+ 7.7048 0.9979 F- 5.1314 0.9997
Hg2+ 7.0341 0.9985 Cd2+ 5.5335 0.9995
Zn2+ 5.2806 0.9997 NO3
- 5.8559 0.9996
Co2+ 5.5572 0.9987 CO3
2- 4.2852 0.9997
Ni2+ 6.1627 0.9988 PO4
3- 5.6543 0.9979
SO4
2- 5.1925 0.9992 Fe3+ 7.5306 0.9982
f interaction between Thioguanine and human serum albumin
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6 X. An et al.pounds within hydrophobic cavities in subdomains IIA and
IIIA, which are corresponding to site I and site II, respectively,
and the sole tryptophan residue (Trp 214) of HSA is in subdo-
main IIA (He and Carter, 1992; Petitpas et al., 2001). There is
a large hydrophobic cavity present in the subdomain IIA to
which many drugs can bind. The crystal structure of HSA in
complex with warfarin was taken from the Brookhaven Pro-
tein Data Bank (entry codes 1h9z). The potential of the 3-D
structure of HSA was assigned according to the Amber 4.0
force ﬁeld with Kollman-all-atom charges. The initial structure
of the thioguanine was generated by molecular modeling soft-
ware Sybyl 6.9.1 (Louis, 2003). The geometry of the molecule
was subsequently optimized to minimal energy using the tripos
force ﬁeld with Gasteiger–Marsili charges. Then it was used to
replace warfarin in the HSA-warfarin crystal structure. At last,
Flexx program was used to establish the interaction mode be-
tween the 6-TG and HSA.
Fig. 7 exhibits the optimal energy ranked result of 6-TG
interaction with the residues of HSA. It can be seen that
the 6-TG molecule was situated within the subdomain IIA
hydrophobic cavity, and the 6-TG was adjacent to hydro-
phobic residues Leu(219), Leu(238), Phe(223), Phe(211),
Glu(292), Val(293), Ala(291), Ala(215), Ala(261), Ile(290),
His(242) etc., of the subdomain IIA of HSA. The results
of molecular modeling suggested that the interaction between
HSA and 6-TG was dominated by hydrophobic force, which
was in agreement with the binding mode proposed in ther-
modynamic analysis. It also provided a good structural basis
to explain the efﬁcient ﬂuorescence quenching of HSA emis-
sion in the presence of 6-TG. In addition, there were some
hydrogen bonds between 6-TG and residues of HSA such
as Arg(222) and Ala(291). Furthermore, this phenomenon
provided a good structural basis to explain the very efﬁcient
ﬂuorescence quenching of HSA emission in the presence of 6-
TG.Figure 7 The interaction model between HSA and 5-iodouri-
dine. The residues of HSA and 6-TG are represented using
different tinctorial stick model. The hydrogen bond between the
ligand and the protein is indicated by dashed line.
Please cite this article in press as: An, X. et al., The investigation o
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An approach for studying the interactions of ﬂuorescent pro-
tein with 6-TG using ﬂuorescence and molecular modeling
techniques was presented. The results showed that HSA ﬂuo-
rescence was quenched by 6-TG through static quenching
and 6-TG could bind to HSA through the hydrophobic inter-
action and hydrogen bond. The biological signiﬁcance of this
work was evident since albumin served as a carrier molecule
for multiple drugs and the interactions of 6-TG with albumin
had not been characterized so far. These experimental and the-
oretical data might be a useful guide for the synthesis of efﬁ-
cient nucleotide drugs, providing some important data for
clinical study of nucleotide drugs, and have a great signiﬁcance
in pharmacology and clinical medicine as well as methodology.Acknowledgements
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